Advisory Council for the Elimination of Tuberculosis, 37583 [06-5876]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 126 / Friday, June 30, 2006 / Notices
37583
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Total ..........................................................................................................
Dated: June 26, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–10343 Filed 6–29–06; 8:45 am]
BILLING CODE 4163–18–P
40,000
Average
burden per
response
(in hours)
........................
........................
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 22, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 06–5876 Filed 6–29–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Council for the Elimination of
Tuberculosis
Centers for Medicare & Medicaid
Services
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following council
meeting:
rwilkins on PROD1PC63 with NOTICES_1
Number of
responses per
respondent
Number of
respondents
Forms
Name: Advisory Council for the
Elimination of Tuberculosis (ACET).
Times and Dates: 8:30 a.m.–5 p.m., July 26,
2006. 8:30 a.m.–12 p.m., July 27, 2006.
Place: Corporate Square, Building 8, 1st
Floor Conference Room, Atlanta, Georgia
30333, Telephone 404/639–8008.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis (TB).
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and application
of new technologies; and reviews the extent
to which progress has been made toward
eliminating TB.
Matters to be Discussed: Agenda items
include issues pertaining to minority health
& health disparities among African
Americans; Federal TB Task Force update; an
update on technical guidance on controlling
TB among the foreign-born guidelines; and
other related TB issues.
Agenda items are subject to change as
priorities dictate.
For Further Information Contact: Paulette
Ford-Knights, National Center for HIV, STD,
and TB Prevention, 1600 Clifton Road, NE.,
M/S E–07, Atlanta, Georgia 30333, Telephone
404/639–8008.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
VerDate Aug<31>2005
16:30 Jun 29, 2006
Jkt 208001
[Document Identifier: CMS–10133, CMS–
10050, and CMS–1515 and 1572]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Competitive
Acquisition Program (CAP) for Medicare
Part B Drugs: Vendor Application and
Bid Form; Use: The CAP Vendor
Application and Bid Form is a
collection tool which will be used by
potential vendors to provide
AGENCY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Total burden
hours
3,333
information related to the characteristics
of their company and to submit their bid
prices for CAP drugs. The information
collected on the CAP Vendor
Application and Bid Form will be used
by CMS during the bidding evaluation
process to evaluate the vendors bid
prices, their credentials, experience and
to assess their ability to provide quality
service to physicians and beneficiaries.
Competitive bidding is seen as a means
of using the dynamics of the
marketplace to provide incentives for
suppliers to provide reasonably priced
products and services of high quality in
an efficient manner. The CAP’s
objectives include providing an
alternative method for physicians to
obtain Part B drugs to administer to
Medicare beneficiaries and reducing
drug acquisition and billing burdens for
physicians; Form Number: CMS–10133
(OMB#: 0938–0955); Frequency:
Reporting-Other, during the bidding
process; Affected Public: Business or
other for-profit; Number of
Respondents: 12; Total Annual
Responses: 12; Total Annual Hours:
480.
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Survey of Newly
Eligible Medicare Beneficiaries; Use:
CMS is responsible for providing
beneficiaries with the Medicare program
information they need to effectively
choose the health care plan best suited
to their needs. In order to provide such
information, CMS needs to know (1)
whether or not new enrollees are aware
of the choices they have, (2) what
beneficiaries understand about the basic
elements of the Medicare program, (3)
what other sources currently provide
Medicare-related information, and (4)
how all of these items vary across
beneficiary subpopulations. To this end,
CMS must have the ability to measure
over time what beneficiaries know and
understand about the Medicare
program. Measuring beneficiaries’
information needs and knowledge over
time will help CMS evaluate its impact
on information/education, population
changes and other initiatives. Form
Number: CMS–10050 (OMB#: 0938–
0869); Frequency: Reporting—Quarterly;
Affected Public: Individuals or
E:\FR\FM\30JNN1.SGM
30JNN1
]]>Agencies
[Federal Register Volume 71, Number 126 (Friday, June 30, 2006)]
[Notices]
[Page 37583]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following council meeting:
Name: Advisory Council for the Elimination of Tuberculosis
(ACET).
Times and Dates: 8:30 a.m.-5 p.m., July 26, 2006. 8:30 a.m.-12
p.m., July 27, 2006.
Place: Corporate Square, Building 8, 1st Floor Conference Room,
Atlanta, Georgia 30333, Telephone 404/639-8008.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis (TB). Specifically, the Council makes recommendations
regarding policies, strategies, objectives, and priorities;
addresses the development and application of new technologies; and
reviews the extent to which progress has been made toward
eliminating TB.
Matters to be Discussed: Agenda items include issues pertaining
to minority health & health disparities among African Americans;
Federal TB Task Force update; an update on technical guidance on
controlling TB among the foreign-born guidelines; and other related
TB issues.
Agenda items are subject to change as priorities dictate.
For Further Information Contact: Paulette Ford-Knights, National
Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE., M/S
E-07, Atlanta, Georgia 30333, Telephone 404/639-8008.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: June 22, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 06-5876 Filed 6-29-06; 8:45 am]
BILLING CODE 4163-18-P
